OVERVIEW

6th Annual Rare Disease Market Access & Commercialization Summit is organized by World Congress and will be held from Feb 05 - 06, 2019 at Hilton Philadelphia at Penn's Landing, Philadelphia, Pennsylvania, United States of America.

Who Should Attend :
• Market Access.
• Rare Disease.
• Orphan Drugs.
• Commercial Strategy/Operations.
• Reimbursement.
• Early/Expanded Access.
• Launch Excellence.
• Product Launch.
• Portfolio Management/Strategy.
• Marketing.
• Development.
• Patient Advocacy.
• Payer Strategy.
• Patient Support/Services.

Conference Description :
The 6th Annual Rare Disease Market Access and Commercialization Summit is an industry-focused event that examines the challenges, innovations, and techniques for achieving commercial success and navigating the reimbursement landscape. Factors such as reimbursement, value determinations, pricing models, financial and clinical support initiatives are discussed from the perspective of key stakeholders, including manufacturers, payers, and advocacy.

• Explore key strategies for rare disease commercialization.
• Gain insight into value-based pricing, market access and reimbursement for orphan drugs.
• Ensure patient support services for rare disease patient populations.
• Understand how to effectively demonstrate value for rare disease therapies.
• Accelerate clinical development of orphan drugs to support market access.

Additional details will be posted as soon as they are available.

KEY DATES

Event Start Date
05 Feb, 2019
Event Start Date
Event End Date
06 Feb, 2019
Event End Date

SPECIALITIES

Infectious Disease

SUGGESTED HOTELS

CONFERENCE VENUE

LocationHilton Philadelphia at Penn's Landing
201 S Christopher Columbus Blvd

RELATED CONFERENCES & LIVE WEBINARS

Aug 21 - 22, 2026 | Singapore, ...

Infectious Disease
More actions
US$149
By American Medical Seminars (AMS),...

Apr 12 - 15, 2027 | Sarasota, Florida,...

Infectious Disease
20 AMA PRA Category 1 Credits™
...
More actions
US$839

Apr 12 - 15, 2027 | Sarasota, Florida,...

Infectious Disease
20 AMA PRA Category 1 Credits™
...
More actions
US$840